CY1108659T1 - Φαρμακευτικες συνθεσεις που περιλαμβανουν ενα αμφοτερικο επιφανειοδραστικο, μια πολυπροποξυλιωμενη κετυλικη αλκοολη και μια πολικη φαρμακευτικη ουσια - Google Patents

Φαρμακευτικες συνθεσεις που περιλαμβανουν ενα αμφοτερικο επιφανειοδραστικο, μια πολυπροποξυλιωμενη κετυλικη αλκοολη και μια πολικη φαρμακευτικη ουσια

Info

Publication number
CY1108659T1
CY1108659T1 CY20081101484T CY081101484T CY1108659T1 CY 1108659 T1 CY1108659 T1 CY 1108659T1 CY 20081101484 T CY20081101484 T CY 20081101484T CY 081101484 T CY081101484 T CY 081101484T CY 1108659 T1 CY1108659 T1 CY 1108659T1
Authority
CY
Cyprus
Prior art keywords
alcohol
multiproproxylenic
ampotheral
pharmaceutical compositions
compositions containing
Prior art date
Application number
CY20081101484T
Other languages
English (en)
Inventor
Brian Hawtin
Original Assignee
Thornton & Ross Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thornton & Ross Limited filed Critical Thornton & Ross Limited
Publication of CY1108659T1 publication Critical patent/CY1108659T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Dispersion Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Μια φόρμουλα, για παράδειγμα ένα γαλάκτωμα λαδιού σε νερό, που περιλαμβάνει ένα αμφοτερικό επιφανειοδραστικό, μια αλκοξυλιωμένη κετυλική αλκοόλη και μια πολική φαρμακευτική ουσία. Η φαρμακευτική ουσία μπορεί να είναι χρωμογλυκικό νάτριο ή νεδοκρομίλη νατριούχος. Η φόρμουλα μπορεί να είναι χρήσιμη στη θεραπεία δερματικών παθήσεων όπως η ατοπική δερματίδια.
CY20081101484T 1998-05-22 2008-12-22 Φαρμακευτικες συνθεσεις που περιλαμβανουν ενα αμφοτερικο επιφανειοδραστικο, μια πολυπροποξυλιωμενη κετυλικη αλκοολη και μια πολικη φαρμακευτικη ουσια CY1108659T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9810949.9A GB9810949D0 (en) 1998-05-22 1998-05-22 Formulation
EP99922371A EP1079804B1 (en) 1998-05-22 1999-05-20 Pharmaceutical compositions comprising an amphoteric surfactant an polypropoxylated cetyl alcohol and a polar drug

Publications (1)

Publication Number Publication Date
CY1108659T1 true CY1108659T1 (el) 2014-04-09

Family

ID=10832479

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20081101484T CY1108659T1 (el) 1998-05-22 2008-12-22 Φαρμακευτικες συνθεσεις που περιλαμβανουν ενα αμφοτερικο επιφανειοδραστικο, μια πολυπροποξυλιωμενη κετυλικη αλκοολη και μια πολικη φαρμακευτικη ουσια

Country Status (13)

Country Link
US (1) US7109246B1 (el)
EP (1) EP1079804B1 (el)
JP (2) JP4230109B2 (el)
AT (1) ATE415943T1 (el)
AU (1) AU3946899A (el)
CA (1) CA2330330C (el)
CY (1) CY1108659T1 (el)
DE (1) DE69940015D1 (el)
DK (1) DK1079804T3 (el)
ES (1) ES2320054T3 (el)
GB (2) GB9810949D0 (el)
PT (1) PT1079804E (el)
WO (1) WO1999060997A1 (el)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070032853A1 (en) 2002-03-27 2007-02-08 Hossainy Syed F 40-O-(2-hydroxy)ethyl-rapamycin coated stent
US6696491B2 (en) 2000-05-12 2004-02-24 Meracol Corporation Limited Treating irritable bowel syndrome or disease
NZ504526A (en) * 2000-05-12 2003-05-30 Meracol Corp Ltd Treating herpes simplex symptoms using a mixture of cetyl myristate and cetyl palmitate
EP1335719B1 (en) * 2000-05-12 2007-12-19 Meracol Corporation Limited Cetyl myristate and cetyl palmitate for treating eczema and/or psoriasis
US20030153620A1 (en) 2000-05-12 2003-08-14 Meakin Timothy David Treating eczema and/or psoriasis
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
US7767698B2 (en) * 2002-06-03 2010-08-03 Mcneil Ab Formulation and use thereof
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
ES2532906T5 (es) 2002-10-25 2022-03-23 Foamix Pharmaceuticals Ltd Espuma cosmética y farmacéutica
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
GB0310147D0 (en) * 2003-05-02 2003-06-04 Almond Julie E A composition for use in the treatment of a skin condition in a subject
US20050118344A1 (en) 2003-12-01 2005-06-02 Pacetti Stephen D. Temperature controlled crimping
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
BRPI0510906A (pt) * 2004-05-19 2007-11-06 Emisphere Tech Inc composição farmacêutica tópica, composição para administração tópica e seu uso
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
WO2008154705A1 (en) * 2007-06-20 2008-12-24 Apollo Life Sciences Limited Transdermal delivery of active agents
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
MX2007009796A (es) 2007-08-14 2009-02-25 Cell Therapy And Technology S Gel conteniendo pirfenidona.
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
US8518376B2 (en) 2007-12-07 2013-08-27 Foamix Ltd. Oil-based foamable carriers and formulations
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
WO2009090558A2 (en) 2008-01-14 2009-07-23 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
WO2010125470A2 (en) 2009-04-28 2010-11-04 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
CA2769625C (en) 2009-07-29 2017-04-11 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013008A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
BR112012007473A2 (pt) 2009-10-02 2019-05-07 Foamix Ltd composições tópicas de tetraciclina e respectivo método de uso
US8685381B2 (en) 2010-10-23 2014-04-01 Joel Schlessinger Topical base and active agent-containing compositions, and methods for improving and treating skin
US8968755B2 (en) 2010-10-23 2015-03-03 Joel Schlessinger Topical base and active agent-containing compositions, and methods for improving and treating skin
MX2011007675A (es) 2011-07-19 2012-07-11 Cell Therapy And Technology S A De C V Procedimiento para la fabricacion de una composicion farmaceutica en forma de tabletas de liberacion prolongada conteniendo pirfenidona y su aplicacion en la regresion de la insuficiencia renal cronica, contractura capsular mamaria y fibrosis hepatica humanas.
JP5930953B2 (ja) * 2011-12-14 2016-06-08 花王株式会社 抗菌剤組成物の製造方法
RU2014141897A (ru) * 2012-03-19 2016-05-20 Др. Аугуст Вольфф Гмбх Унд Ко. Кг Арцнаймиттель Применение амфотерных поверхностно-активных веществ для предупреждения и лечения патогенных влагалищных биопленок во влагалищных инфекциях
MX346763B (es) 2012-03-28 2017-03-31 Cell Therapy And Tech S A De C V Composición tópica semisólida conteniendo pirfenidona y dialil óxido de disulfuro modificado (odd-m) para eliminar o prevenir el acné.
MX356551B (es) * 2012-08-23 2018-06-04 Grupo Medifarma S A De C V Star Composición antiséptica, antiseborreica y exfoliante para eliminar o prevenir el acné.
PL3104853T3 (pl) 2014-02-10 2020-05-18 Respivant Sciences Gmbh Leczenie stabilizatorami komórek tucznych zaburzeń ogólnoustrojowych
CA2938996A1 (en) 2014-02-10 2015-08-13 Patara Pharma, LLC Methods for the treatment of lung diseases with mast cell stabilizers
US10238625B2 (en) 2015-08-07 2019-03-26 Respivant Sciences Gmbh Methods for the treatment of mast cell related disorders with mast cell stabilizers
US10265296B2 (en) 2015-08-07 2019-04-23 Respivant Sciences Gmbh Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders
JP2019528320A (ja) 2016-08-31 2019-10-10 レシュピファント サイエンシス ゲゼルシャフト ミット ベシュレンクター ハフトゥングＲｅｓｐｉｖａｎｔ Ｓｃｉｅｎｃｅｓ Ｇｍｂｈ 特発性肺線維症による慢性咳の治療のためのクロモリン組成物
MX2020012139A (es) 2016-09-08 2021-01-29 Vyne Pharmaceuticals Inc Composiciones y metodos para tratar rosacea y acne.
CN109803724A (zh) 2016-10-07 2019-05-24 瑞思皮万特科学有限责任公司 用于治疗肺纤维化的色甘酸组合物
MX366086B (es) 2017-08-15 2019-06-27 Cell Therapy And Tech S A De C V Composicion topica semisolida conteniendo un agente antimicrobiano y pirfenidona para el tratamiento de daños cronicos de la piel.
GB2587402B (en) * 2019-09-27 2023-05-10 Hewlett Healthcare Ltd Formulation

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3974270A (en) 1972-11-03 1976-08-10 Colgate-Palmolive Company Pressurized composition for the production of a dry spray of mild but effective non-staining antiperspirant
GB1475503A (en) 1973-12-19 1977-06-01 Fisons Ltd Topical compositions
GB1537047A (en) 1975-10-03 1978-12-29 Fisons Ltd Eye ointment
FR2546407B1 (fr) * 1983-05-24 1986-04-18 Therapeutique Applic Sa Medicament a activite anti-allergique pour administration locale a base d'acide n-acetyl(a,b)-aspartyl glutamique
EP0189861A3 (en) * 1985-01-26 1988-02-17 Showa Denko Kabushiki Kaisha Percutaneous absorption accelerator for ionic water-soluble medicine
JPS6261929A (ja) * 1985-09-13 1987-03-18 Showa Denko Kk 水溶性薬物の経皮吸収性を高めた皮膚外用剤
DE3583237D1 (de) * 1985-07-10 1991-07-18 Richardson Gmbh Reinigungsschaum fuer zaehne.
US5190917A (en) * 1986-12-24 1993-03-02 John Lezdey Treatment of psoriasis
JPS63230641A (ja) * 1987-03-19 1988-09-27 Shiseido Co Ltd 経皮吸収促進剤及びこれを含有する皮膚外用製剤
GB2202145B (en) 1987-03-17 1991-01-02 Fisons Plc Compositions of nedocromil for dermatological use.
US4883792A (en) * 1989-01-17 1989-11-28 Peter Timmins Steroid cream formulation
GB8912391D0 (en) * 1989-05-30 1989-07-12 Unilever Plc Shampoo composition
CA2035758C (en) * 1990-03-06 2002-04-02 Yataka Murata Antimycotic external imidazole preparations
US5696110A (en) * 1991-10-24 1997-12-09 Merck, Sharp & Dohme, Ltd. Benzodiazepine derivatives and their use as antagonists of cholecystokinin and/or gastrin receptors
US5254109A (en) * 1992-12-07 1993-10-19 Creative Products Resource Associates, Ltd. Separately packaged applicator pads for topical delivery of incompatable drugs
FR2699169B1 (fr) * 1992-12-16 1995-02-03 Oreal Nouveaux sels d'amines primaires dérivés d'acides aminés à groupement uréthanne, et leur utilisation dans des compositions cosmétiques.
JPH06305934A (ja) * 1993-04-23 1994-11-01 Pola Chem Ind Inc エアゾール型化粧料
US6231844B1 (en) * 1995-04-13 2001-05-15 The Procter & Gamble Company Nonionic surfactant foaming agents for foaming cosmetic compositions
JPH08319212A (ja) * 1995-05-24 1996-12-03 Kanebo Ltd エアゾール組成物
JPH09157161A (ja) 1995-12-13 1997-06-17 Lion Corp 皮膚疾患治療剤
JPH09157172A (ja) 1995-12-13 1997-06-17 Lion Corp 皮膚外用剤及び湿疹薬
AU1844197A (en) * 1996-02-02 1997-08-22 Estee Lauder Inc. Skin smoothing compositions containing hydroxyacids and methods for using same
FR2745496B1 (fr) * 1996-03-01 1998-04-30 Oreal Dispositif pressurise transparent a composition moussante comprenant des tensioactifs non-ioniques et amphoteres
ATE218319T1 (de) * 1996-03-08 2002-06-15 Disperse Ltd Dispersion eines öligen, zwei flüssigkeiten enthaltenden schaums und eines wässrigen gels
US6143310A (en) * 1996-06-27 2000-11-07 The Procter & Gamble Company Cosmetic compositions
US5837274A (en) * 1996-10-22 1998-11-17 Kimberly Clark Corporation Aqueous, antimicrobial liquid cleaning formulation
US6150400A (en) * 1997-06-30 2000-11-21 Presutti Laboratories Method for treating vulvar vestibulitis
US6150403A (en) * 1997-10-14 2000-11-21 The Procter & Gamble Company Topical compositions for regulating the oily/shiny appearance of skin
US6207694B1 (en) * 1998-07-27 2001-03-27 Howard Murad Pharmaceutical compositions and methods for managing scalp conditions
US6071541A (en) * 1998-07-31 2000-06-06 Murad; Howard Pharmaceutical compositions and methods for managing skin conditions
US6177092B1 (en) * 1998-11-10 2001-01-23 Color Access, Inc. Self-foaming cleansing systems

Also Published As

Publication number Publication date
EP1079804B1 (en) 2008-12-03
AU3946899A (en) 1999-12-13
GB2337461B (en) 2003-10-01
DK1079804T3 (da) 2009-03-30
GB9911733D0 (en) 1999-07-21
JP2002530271A (ja) 2002-09-17
ATE415943T1 (de) 2008-12-15
DE69940015D1 (de) 2009-01-15
ES2320054T3 (es) 2009-05-18
JP4230109B2 (ja) 2009-02-25
PT1079804E (pt) 2009-02-05
GB2337461A (en) 1999-11-24
US7109246B1 (en) 2006-09-19
CA2330330A1 (en) 1999-12-02
EP1079804A1 (en) 2001-03-07
WO1999060997A1 (en) 1999-12-02
JP2008273985A (ja) 2008-11-13
GB9810949D0 (en) 1998-07-22
CA2330330C (en) 2009-09-15

Similar Documents

Publication Publication Date Title
CY1108659T1 (el) Φαρμακευτικες συνθεσεις που περιλαμβανουν ενα αμφοτερικο επιφανειοδραστικο, μια πολυπροποξυλιωμενη κετυλικη αλκοολη και μια πολικη φαρμακευτικη ουσια
ATE374591T1 (de) Schäumende kosmetische creme zur behandlung von fettiger haut
AR020288A1 (es) Emulsion aceite en agua que comprende un agente biologicamente activo micronizado y un sistema emulsionante adecuado.
BR0100424A (pt) Nanoemulsão óleo-em-água que contém lipìdios anfìfilos e um polìmero não iÈnico, composição cosmética de uso tópico, suas utilizações, processo de tratamento não terapêutico e processo para espessar as nanoemulsões óleo-em -água
FI953442A (fi) Gonadotropiinia sisältäviä pakastekuivattuja pallosia
ES2107824T3 (es) Procedimiento para el secado subcritico de aerogeles.
NO20031249D0 (no) Emulsjonspreparater samt konsentrater derav
ATE283031T1 (de) Nichtirritierende kosmetische und pharmazeutische zusammensetzungen
DE69500095D1 (de) Wie Milch aussehende Öl-in-Wasser reinigende Emulsion
BR9903100A (pt) Composição anidra, processo de tratamento não terapêutico da pele e/ou do couro cabeludo e utilização de um silicone oxialquilenado substituìdo em (-(
FR2840903B1 (fr) Derive de glucose et de vitamine f, compositions le comprenant et utilisations pour ameliorer l'etat des poils et des cheveux
ATE270544T1 (de) Halbfeste arzneizubereitung enthaltend isotretinoin
HUP0104235A2 (hu) Parazitaellenes készítmények
DE59909759D1 (de) Emulgatorfreie und bornitrid enthaltende feindisperse systeme vom typ öl-in-wasser und wasser-in-öl
ECSP034883A (es) Amidas de acidos antranilicos con cadena lateral de heteroarilsulfonilo, procedimiento para su preparacion, su empleo como medicamento o agente de diagnostico, asi como preparados farmaceuticos que las contienen
HK1053795A1 (en) New self emulsifying drug delivery system
HUP0302403A2 (hu) Olajban oldható komponenseket és 2-6 HLB-értékű W/O-emulgeátorokat és adott esetben egy vagy több szokásos adalékot tartalmazó bőrolajok, alkalmazásuk, valamint eljárás előállításukra
BR9901146A (pt) Emulsão água-em-óleo; composição para uso coméstico, dermatológico, farmacêutico ou higiênico e processo de tratamento não-terapêutico para a pele e/ou fibras de queratina.
BR0116972A (pt) Métodos e dispositivos para administração de substâncias na camada intradérmica da pele para absorção sistêmica
ATE329570T1 (de) Emulsion enthaltend siliconöl- und co- lösungsmittelsystem enhaltend fettlösliche kosmetische wirkstoffe und daraus hergestelleten kosmetischen zubereitungen
ES2179667T3 (es) Nuevas formulaciones inyectables que contienen ramoplanina.
ATE277622T1 (de) Arzneimittel enthaltend xenogene oligo- oder/und polyribonukleotide
BR0317247A (pt) Dispositivo para aplicação ocular de princìpios ativos por via transpalpebral
BR0111094A (pt) Composição farmacêutica, uso de uma composição farmacêutica estéril, e, método para melhorar a sobrevida em um paciente criticamente doente
WO2004093832A3 (fr) Composition cosmetique ou pharmaceutique comprenant l’association d’au moins un diacylglycerol et d’au moins un alcool gras